Introduction Affecting 2.3 million people worldwide, multiple sclerosis is a neurodegenerative autoimmune disease. Research into new treatments and cures is ongoing. One such study has found that stem cell therapy may delay the progression of the disease. While stem cell research is still in the beginning phases, these new results

Introduction Multiple sclerosis is an autoimmune disease that affects 2.3 million people worldwide. Current treatment is expensive and limited, but new research is being done every day. One promising trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) compares stem cell experimental therapies to current treatments. Multiple

Multiple sclerosis is a chronic disease that affects many people in different ways. Its cause, symptoms, diagnosis, and treatment are all complicated. Scientists believe the disease is caused by a variety of factors. To understand the best diagnosis and treatment is important to understand the cause and symptoms of the

For many patients, multiple sclerosis is a chronic disease that they live with but of which they understand very little. It is a chronic disease that has a variety of symptoms that are unique to the individual. The exact origin is not well understood, but scientists believe the disease is

The Nervous System The body is filled with billions of nerves. Some of them travel from the brain, to muscles and skin, and then back again to the brain. Some of the nerves are covered in a myelin sheath. Myelin is a mixture of proteins and other compounds. It forms

A clinical trial published in January of this year, supported the results of previous studies, showing stem cell therapy to be a safe and effective treatment for patients with multiple sclerosis. Traditional, disease modifying treatment is able to reduce flare-ups and slow the progression of MS, however, this type of

Multiple Sclerosis (MS), is a chronic, immune-mediated disease where the immune system mistakenly attacks healthy tissue in the central nervous system (brain, spinal cord, and optic nerves). Muscle weakness, spasticity, fatigue and a loss of coordination can lead to a progressive worsening of mobility and impair a person’s ability to

In our March 23rd article, ”Stem Cell Transplants Could Provide Long-Term Remission for Patients with MS” we shared the positive 3 year results of stem cell transplant in patients with remitting-relapsing MS. In this article, we will share with you the results from a 5 year trial sponsored by the

An international clinical trial evaluating the safety and efficacy of stem cells for the treatment of MS showed stem cell transplantation could halt the progression, improve symptoms of the disease and reduce disability for patients with remitting-relapsing MS. Note: Despite all advances in stem cells research and the application of

Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease of the central nervous system.  The disease is characterized by recurrent episodes of focal inflammatory demyelination resulting in neurological symptoms. The National Multiple Sclerosis Society has identified four disease categories to help distinguish the differences between how the disease presents in

Many studies have been conducted to evaluate if exercise can help slow the progression of multiple sclerosis. An analysis of the different studies could not establish clearly if exercise slowed the progression of the disease but it is clear that exercise is helpful for managing several of the symptoms of

There are many clinical trials in progress around the world using stem cells as a treatment for different diseases including multiple sclerosis. Recent results, in an important clinical trial, provide evidence that high-dose immunosuppressive therapy followed by autologous stem cell transplantation can induce sustained remission of the disease. In addition, research